| Bid Price | 1.70p | High Price | 2.00p |
|---|
| Ask Price | 2.00p | Low Price | 1.50p |
|---|
| Open Price | 1.55p | Spread | 15.00% |
|---|
| Prev Close | 1.55p | Volume | 4,835,813 |
|---|
Genflow Biosciences PLC Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Nov 28, 2025 | 1.55 | 2.00 | 1.50 | 1.85 | 4,835,813 |
| Nov 27, 2025 | 1.63 | 1.65 | 1.50 | 1.55 | 2,110,368 |
| Nov 26, 2025 | 1.70 | 1.75 | 1.50 | 1.63 | 1,808,549 |
| Nov 25, 2025 | 1.70 | 1.80 | 1.40 | 1.70 | 8,141,971 |
| Nov 24, 2025 | 1.80 | 1.90 | 1.61 | 1.70 | 1,621,197 |
Genflow Biosciences PLC Information
| Name | Genflow Biosciences PLC | Index | |
|---|
| ISIN | GB00BP2C3V08 | Epic | GENF |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | SSQ3 |
|---|
| Industry | Biotechnology | Sector | Healthcare |
|---|
| EMS | 200,000 | Trading Status | Closed |
|---|
| Shares in Issue | 493.55 m | Prev Close | 1.55p |
|---|
| PE Ratio | | Market Cap | £9.13 m |
|---|
| Div Yield | 0 | Div per Share | £NaN |
|---|
| EPS | £-0.00 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | n/a | DPS Growth (%) | 0 |
|---|
| Current Ratio | 0.605215 | Quick Ratio | 0.469985 |
|---|
Genflow Biosciences PLC Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 16/10/25 | PLAC | Eric Leire | CEO | 40,000,000 @ £0.01 | £440,000.00 |
| 15/05/25 | PLAC | Eric Leire | CEO | 62,500,000 @ £0.01 | £500,000.00 |
| 28/03/25 | BUY | Eric Leire | CEO | 2,100,000 @ £0.01 | £24,150.00 |
| 15/08/22 | BUY | Eric Leire | CEO | 106,000 @ £0.03 | £2,968.00 |
| 20/07/22 | BUY | Yassine Bendiabdallah | CH | 108,000 @ £0.04 | £3,996.00 |
| 20/07/22 | BUY | Peter King-Lewis | NED | 82,000 @ £0.04 | £3,034.00 |
| 19/07/22 | BUY | Eric Leire | CEO | 308,999 @ £0.03 | £9,363.00 |
Genflow Biosciences PLC News
